• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合蛋白质-配体对接和半经验量子力学预测酶抑制作用(IC)

Prediction of enzyme inhibition (IC) using a combination of protein-ligand docking and semiempirical quantum mechanics.

作者信息

Glen Robert C, Cole Jason C, Stewart James J P

机构信息

Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB21EW, UK.

Department of Metabolism Digestion and Reproduction, Imperial College London, Hammersmith Hospital Campus, Burlington Danes Building, Du Cane Road, London, W12 0NN, UK.

出版信息

J Mol Model. 2025 Jul 12;31(8):209. doi: 10.1007/s00894-025-06423-7.

DOI:10.1007/s00894-025-06423-7
PMID:40650762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12255584/
Abstract

CONTEXT

The ability to predict the relative binding energies of ligands to a biological receptor would be of great value in drug discovery. However, accurately calculating the predicted binding energies is limited by the high accuracy required, by the presence of multiple minima on the potential energy surface, and by issues specific to the intrinsic properties of the binding site, such as details of the geometry of the ligand-protein complex. To address these issues, a systematic analysis of potential sources of error was carried out which resulted in a few relatively small changes being made to the MOPAC program.

METHODS

A set of 77 ligands was constructed for which experimentally determined IC values were available. For each of the ligands, prediction of the protein-ligand interaction energy was carried out in two distinct stages. In the first stage, the Protein-Ligand docking program GOLD was used to generate several distinct conformations of the ligand bound to a protein. The geometries of these systems were then optimised using the MOPAC program. A comparison of the relative binding energies of the ligands with the reported IC values showed a very poor predictive power. By partitioning the ligand set into two subsets, and eliminating six ligands that were inconsistent with the experimental results, a large increase in accuracy was obtained.

摘要

背景

预测配体与生物受体的相对结合能的能力在药物发现中具有重要价值。然而,准确计算预测的结合能受到所需高精度的限制,受到势能面上多个极小值的存在的限制,以及受到结合位点固有特性所特有的问题的限制,例如配体 - 蛋白质复合物几何结构的细节。为了解决这些问题,对潜在的误差来源进行了系统分析,结果对MOPAC程序进行了一些相对较小的修改。

方法

构建了一组77种配体,其具有可获得的实验测定的IC值。对于每种配体,在两个不同阶段进行蛋白质 - 配体相互作用能的预测。在第一阶段,使用蛋白质 - 配体对接程序GOLD生成与蛋白质结合的配体的几种不同构象。然后使用MOPAC程序优化这些系统的几何结构。将配体的相对结合能与报道的IC值进行比较,结果显示预测能力非常差。通过将配体集划分为两个子集,并剔除六个与实验结果不一致的配体,准确性得到了大幅提高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/366afc3df7d2/894_2025_6423_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/21c7314d5a0f/894_2025_6423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/145e83762456/894_2025_6423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/91465fda06ac/894_2025_6423_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/376fc28be15c/894_2025_6423_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/3e1e7e2a32df/894_2025_6423_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/25e67ba26816/894_2025_6423_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/aeb3c071188d/894_2025_6423_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/cdbf3c397bec/894_2025_6423_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/9d36ab56b078/894_2025_6423_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/a23ddcaf2d61/894_2025_6423_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/366afc3df7d2/894_2025_6423_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/21c7314d5a0f/894_2025_6423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/145e83762456/894_2025_6423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/91465fda06ac/894_2025_6423_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/376fc28be15c/894_2025_6423_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/3e1e7e2a32df/894_2025_6423_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/25e67ba26816/894_2025_6423_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/aeb3c071188d/894_2025_6423_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/cdbf3c397bec/894_2025_6423_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/9d36ab56b078/894_2025_6423_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/a23ddcaf2d61/894_2025_6423_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e62/12255584/366afc3df7d2/894_2025_6423_Fig11_HTML.jpg

相似文献

1
Prediction of enzyme inhibition (IC) using a combination of protein-ligand docking and semiempirical quantum mechanics.结合蛋白质-配体对接和半经验量子力学预测酶抑制作用(IC)
J Mol Model. 2025 Jul 12;31(8):209. doi: 10.1007/s00894-025-06423-7.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
CorrEA: A Web Server for Optimizing Correlations between Calculated Energies and Activities in Ligand-Receptor Systems Considering Multiple Binding Site Conformations.CorrEA:一个用于考虑多种结合位点构象优化配体-受体系统中计算能量与活性之间相关性的网络服务器。
J Chem Inf Model. 2025 Jul 14;65(13):7113-7128. doi: 10.1021/acs.jcim.5c00571. Epub 2025 Jun 23.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
10
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.

本文引用的文献

1
Water in drug design: pitfalls and good practices.药物设计中的水:陷阱与良好实践
Expert Opin Drug Discov. 2025 Jun;20(6):745-764. doi: 10.1080/17460441.2025.2497912. Epub 2025 Apr 27.
2
Improved Rapid Equilibrium Dialysis-Mass Spectrometry (RED-MS) Method for Measuring Small Molecule-Protein Complex Binding Affinities in Solution.用于测量溶液中小分子-蛋白质复合物结合亲和力的改进型快速平衡透析-质谱法(RED-MS)
J Am Soc Mass Spectrom. 2024 Dec 4;35(12):2785-2789. doi: 10.1021/jasms.4c00334. Epub 2024 Nov 4.
3
Protein characteristics substantially influence the propensity of activity cliffs among kinase inhibitors.
蛋白质特性极大地影响了激酶抑制剂中活性峰的倾向。
Sci Rep. 2024 Apr 20;14(1):9058. doi: 10.1038/s41598-024-59501-w.
4
Combining IC or Values from Different Sources Is a Source of Significant Noise.合并来自不同来源的IC或值是显著噪声的一个来源。
J Chem Inf Model. 2024 Mar 11;64(5):1560-1567. doi: 10.1021/acs.jcim.4c00049. Epub 2024 Feb 23.
5
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.开发针对 SARS-CoV-2 主蛋白酶的高效非共价抑制剂的开放科学发现。
Science. 2023 Nov 10;382(6671):eabo7201. doi: 10.1126/science.abo7201.
6
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease.H163A 突变使 SARS-CoV-2 主蛋白酶的氧化构象展开。
Nat Commun. 2023 Sep 12;14(1):5625. doi: 10.1038/s41467-023-40023-4.
7
Perspectives on Ligand/Protein Binding Kinetics Simulations: Force Fields, Machine Learning, Sampling, and User-Friendliness.配体/蛋白质结合动力学模拟的观点:力场、机器学习、采样和用户友好性。
J Chem Theory Comput. 2023 Sep 26;19(18):6047-6061. doi: 10.1021/acs.jctc.3c00641. Epub 2023 Sep 1.
8
The Magic Methyl and Its Tricks in Drug Discovery and Development.神奇的甲基及其在药物研发中的作用
Pharmaceuticals (Basel). 2023 Aug 15;16(8):1157. doi: 10.3390/ph16081157.
9
A semiempirical method optimized for modeling proteins.一种用于蛋白质建模的半经验方法。
J Mol Model. 2023 Aug 22;29(9):284. doi: 10.1007/s00894-023-05695-1.
10
Design of Tracers in Fluorescence Polarization Assay for Extensive Application in Small Molecule Drug Discovery.荧光偏振分析中示踪剂的设计在小分子药物发现中的广泛应用。
J Med Chem. 2023 Aug 24;66(16):10934-10958. doi: 10.1021/acs.jmedchem.3c00881. Epub 2023 Aug 10.